MARKET

ACOG

ACOG

Alpha Cognition
NASDAQ
5.10
+0.60
+13.33%
After Hours: 5.15 +0.05 +0.98% 18:46 02/06 EST
OPEN
4.650
PREV CLOSE
4.500
HIGH
5.20
LOW
4.600
VOLUME
28.73K
TURNOVER
--
52 WEEK HIGH
11.54
52 WEEK LOW
3.750
MARKET CAP
110.88M
P/E (TTM)
-3.7319
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACOG last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at ACOG last week (0119-0123)?
Weekly Report · 01/26 10:24
Weekly Report: what happened at ACOG last week (0112-0116)?
Weekly Report · 01/19 10:30
Biotech Alert: Searches spiking for these stocks today
TipRanks · 01/16 17:10
Alpha Cognition Grants Equity Awards to Executive Team Under 2025 Incentive Plan
Reuters · 01/15 22:28
Weekly Report: what happened at ACOG last week (0105-0109)?
Weekly Report · 01/12 10:29
Alpha Cognition Targets 2,000 ZUNVEYL Prescribers In 2026; Plans 3 Long-Term Care Alzheimer's Studies; Anticipates $3M Asia Licensing Milestone; Aims For Operating Profitability In 2027
Benzinga · 01/07 21:35
Alpha Cognition Announces 2026 Strategy Focused on Expanding ZUNVEYL Prescriber Base, Increasing Long-Term Care Penetration, Initiating New Studies, and Growing International Licensing Opportunities
Reuters · 01/07 21:30
More
About ACOG
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company's ZUNVEYL (benzgalantamine) product is a delayed release oral tablet formulation indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults. Its pre-clinical development programs include ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mTBI; ALPHA-0602; ALPHA-0702 & ALPHA-0802 (Progranulin and Progranulin GEM’s) for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis or Lou Gehrig’s disease and spinal muscular atrophy, and ALPHA-1062 for the treatment of acute pancreatitis.

Webull offers Alpha Cognition Inc stock information, including NASDAQ: ACOG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACOG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACOG stock methods without spending real money on the virtual paper trading platform.